GenMark Diagnostics, Inc. (GNMK)

[mick]

Needham & Company LLC Reiterates “Buy” Rating for GenMark Diagnostics (NASDAQ:GNMK)
Posted by ABMN Staff on Mar 20th, 2020 // No Comments

https://www.americanbankingnews.com/2020/03/20/needham-company-llc-reiterates-buy-rating-for-genmark-diagnostics-nasdaqgnmk.html

GenMark Diagnostics (NASDAQ:GNMK)‘s stock had its “buy” rating
reiterated by analysts at Needham & Company LLC in a research note
issued to investors on Friday, http://www.AnalystRatings.com reports.

They currently have a $11.00 price objective on the medical equipment provider’s stock. Needham & Company LLC’s price target suggests a

potential upside of 105.22% from the company’s current price.